D3 Bio Investigative Site 1404

New Haven, Connecticut 06511

1 studies enrolling now · 1 studies all time

What they study most

KRAS P.G12D

Studies at this site

• A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation. — Recruiting now